ArticlebioRxiv : the preprint server for biology2024
Discovery of Novel, Potent and Orally Bioavailable SMARCA2 PROTACs with Synergistic Anti-tumor Activity in Combination with KRAS G12C Inhibitors.
Sasikumar Kotagiri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.